As of 2025-10-18, the Relative Valuation of Evolent Health Inc (EVH) is (40.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.53 USD, the upside of Evolent Health Inc based on Relative Valuation is -637.4%.
The range of the Relative Valuation is (42.92) - (39.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 38.7x - 45.5x | 41.0x |
| Forward P/E multiples | 30.4x - 35.6x | 31.8x |
| Fair Price | (42.92) - (39.54) | (40.47) |
| Upside | -670.0% - -625.1% | -637.4% |
| Date | P/E |
| 2025-10-17 | -6.78 |
| 2025-10-16 | -7.03 |
| 2025-10-15 | -7.06 |
| 2025-10-14 | -6.94 |
| 2025-10-13 | -6.92 |
| 2025-10-10 | -7.15 |
| 2025-10-09 | -7.36 |
| 2025-10-08 | -7.25 |
| 2025-10-07 | -7.31 |
| 2025-10-06 | -7.43 |
| 2025-10-03 | -7.41 |
| 2025-10-02 | -7.11 |
| 2025-10-01 | -7.23 |
| 2025-09-30 | -7.62 |
| 2025-09-29 | -7.90 |
| 2025-09-26 | -8.06 |
| 2025-09-25 | -8.03 |
| 2025-09-24 | -8.66 |
| 2025-09-23 | -7.56 |
| 2025-09-22 | -7.74 |
| 2025-09-19 | -7.55 |
| 2025-09-18 | -7.87 |
| 2025-09-17 | -7.69 |
| 2025-09-16 | -7.78 |
| 2025-09-15 | -7.76 |
| 2025-09-12 | -8.13 |
| 2025-09-11 | -8.39 |
| 2025-09-10 | -8.28 |
| 2025-09-09 | -9.00 |
| 2025-09-08 | -8.71 |
| 2025-09-05 | -8.66 |
| 2025-09-04 | -8.55 |
| 2025-09-03 | -8.63 |
| 2025-09-02 | -8.66 |
| 2025-08-29 | -8.69 |
| 2025-08-28 | -8.68 |
| 2025-08-27 | -8.67 |
| 2025-08-26 | -8.35 |
| 2025-08-25 | -8.74 |
| 2025-08-22 | -8.65 |
| 2025-08-21 | -7.90 |
| 2025-08-20 | -8.07 |
| 2025-08-19 | -8.11 |
| 2025-08-18 | -8.13 |
| 2025-08-15 | -8.38 |
| 2025-08-14 | -7.94 |
| 2025-08-13 | -8.08 |
| 2025-08-12 | -7.93 |
| 2025-08-11 | -8.31 |
| 2025-08-08 | -8.11 |